Internal Medicine, Pulmonary Disease · Vernon, CT
NPI
1831145549
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
27 Naek Rd, Suite 2
Vernon, CT, 06066
Phone (860) 875-2444
Groups this clinician bills Medicare through
Medicare paid, 2024
$156K
6,907 services
Medicare patients, 2024
284
Average age 75
Drug cost, 2024
$2.5M
3,832 prescriptions
Company payments, 2025
$2,361
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Faustinus C Onyirimba was code 95004 (test - miscellaneous), 1,555 times for 20 patients. In total Faustinus C Onyirimba billed 6,907 services in 38 codes, and Medicare paid $156K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-02-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 1,555 | 20 | $2.89 | $4,491 |
| 95144 Treatment - Miscellaneous | Office | 1,310 | 18 | $13.51 | $18K |
| 99214 Office E&M - Established | Office | 337 | 203 | $94.85 | $32K |
| 95024 Test - Miscellaneous | Office | 265 | 19 | $6.68 | $1,769 |
| 94727 Pulmonary Function Testing | Office | 117 | 106 | $34.23 | $4,005 |
| 94729 Pulmonary Function Testing | Office | 117 | 106 | $42.91 | $5,021 |
| 94664 E&M - Miscellaneous | Office | 116 | 105 | $14.60 | $1,693 |
| 99215 Office E&M - Established | Office | 113 | 78 | $145.22 | $16K |
| 94618 Pulmonary Function Testing | Office | 111 | 99 | $26.67 | $2,960 |
| 94060 Pulmonary Function Testing | Office | 83 | 76 | $30.54 | $2,535 |
| 99205 Office E&M - New | Office | 52 | 52 | $158.58 | $8,246 |
| 94010 Pulmonary Function Testing | Office | 43 | 40 | $21.00 | $903 |
| 99223 Hospital E&M - Initial | Facility | 15 | 15 | $140.68 | $2,110 |
| 95012 Pulmonary | Office | 12 | 11 | $14.84 | $178 |
| G0008 Administration of influenza virus vaccine | Office | 11 | 11 | $31.04 | $341 |
By year: 2022 $128K for 5,577 services; 2023 $97K for 5,937 services; 2024 $156K for 6,907 services.
Medicare prescription drug claims, 2024
In 2024, the drug Faustinus C Onyirimba prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 818 prescriptions and refills. In total Faustinus C Onyirimba wrote 3,832 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 818 | 1,431 | 200 | $914K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 478 | 665 | 151 | $14K |
| Montelukast Sodium Generic | 268 | 717 | 75 | $3,579 |
| Breo Ellipta Fluticasone/Vilanterol | 254 | 419 | 62 | $166K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 216 | 354 | 55 | $163K |
| Prednisone Generic | 210 | 266 | 130 | $850 |
| Azithromycin Generic | 127 | 221 | 73 | $1,523 |
| Levocetirizine Dihydrochloride Generic | 110 | 255 | 28 | $1,577 |
| Fluticasone Propionate Generic | 109 | 234 | 43 | $1,967 |
| Symbicort Budesonide/Formoterol Fumarate | 77 | 113 | 20 | $26K |
| Doxycycline Hyclate Generic | 75 | 75 | 60 | $729 |
| Azelastine Hcl Generic | 70 | 144 | 23 | $3,153 |
| Azelastine-Fluticasone Azelastine/Fluticasone | 70 | 130 | 30 | $11K |
| Roflumilast Generic | 66 | 86 | Under 11 | $2,410 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 58 | 134 | 22 | $13K |
Brand drugs: 2,168 claims; generic drugs: - claims; opioid claims: 12.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Faustinus C Onyirimba $2,361 ($2,361 in general payments such as food, travel and fees) from 23 companies. The largest payer was GlaxoSmithKline, LLC. with $591.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 42 | $591 |
| AstraZeneca Pharmaceuticals LP AZN | 13 | $306 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 8 | $222 |
| Verona Pharma, Inc. VRNA | 6 | $159 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $108 |
| Actelion Pharmaceuticals US, Inc. JNJ | 4 | $101 |
| Regeneron Healthcare Solutions, Inc. REGN | 5 | $96.77 |
| Genentech USA, Inc. ROG.SW | 4 | $93.71 |
| Amgen Inc. AMGN | 4 | $91.96 |
| Genzyme Corporation SNY | 4 | $87.03 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.